Global Demerol (Meperidine) Market Research Report 2019
1 Study Coverage
- 1.1 Demerol (Meperidine) Product Introduction
- 1.2 Market Segments
- 1.3 Key Demerol (Meperidine) Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Demerol (Meperidine) Market Size Growth Rate by Type
- 1.4.2 Powder
- 1.4.3 Liquid
- 1.5 Market by Application
- 1.5.1 Global Demerol (Meperidine) Market Size Growth Rate by Application
- 1.5.2 Anesthesia
- 1.5.3 Cough Treatment
- 1.5.4 Diarrhea Treatment
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Demerol (Meperidine) Market Size, Estimates and Forecasts
- 2.1.1 Global Demerol (Meperidine) Revenue 2015-2026
- 2.1.2 Global Demerol (Meperidine) Sales 2015-2026
- 2.2 Global Demerol (Meperidine), Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Demerol (Meperidine) Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Demerol (Meperidine) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Demerol (Meperidine) Competitor Landscape by Players
- 3.1 Demerol (Meperidine) Sales by Manufacturers
- 3.1.1 Demerol (Meperidine) Sales by Manufacturers (2015-2020)
- 3.1.2 Demerol (Meperidine) Sales Market Share by Manufacturers (2015-2020)
- 3.2 Demerol (Meperidine) Revenue by Manufacturers
- 3.2.1 Demerol (Meperidine) Revenue by Manufacturers (2015-2020)
- 3.2.2 Demerol (Meperidine) Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Demerol (Meperidine) Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Demerol (Meperidine) Revenue in 2019
- 3.2.5 Global Demerol (Meperidine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Demerol (Meperidine) Price by Manufacturers
- 3.4 Demerol (Meperidine) Manufacturing Base Distribution, Product Types
- 3.4.1 Demerol (Meperidine) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Demerol (Meperidine) Product Type
- 3.4.3 Date of International Manufacturers Enter into Demerol (Meperidine) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Demerol (Meperidine) Market Size by Type (2015-2020)
- 4.1.1 Global Demerol (Meperidine) Sales by Type (2015-2020)
- 4.1.2 Global Demerol (Meperidine) Revenue by Type (2015-2020)
- 4.1.3 Demerol (Meperidine) Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Demerol (Meperidine) Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Demerol (Meperidine) Sales Forecast by Type (2021-2026)
- 4.2.2 Global Demerol (Meperidine) Revenue Forecast by Type (2021-2026)
- 4.2.3 Demerol (Meperidine) Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Demerol (Meperidine) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Demerol (Meperidine) Market Size by Application (2015-2020)
- 5.1.1 Global Demerol (Meperidine) Sales by Application (2015-2020)
- 5.1.2 Global Demerol (Meperidine) Revenue by Application (2015-2020)
- 5.1.3 Demerol (Meperidine) Price by Application (2015-2020)
- 5.2 Demerol (Meperidine) Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Demerol (Meperidine) Sales Forecast by Application (2021-2026)
- 5.2.2 Global Demerol (Meperidine) Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Demerol (Meperidine) Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Demerol (Meperidine) by Country
- 6.1.1 North America Demerol (Meperidine) Sales by Country
- 6.1.2 North America Demerol (Meperidine) Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Demerol (Meperidine) Market Facts & Figures by Type
- 6.3 North America Demerol (Meperidine) Market Facts & Figures by Application
7 Europe
- 7.1 Europe Demerol (Meperidine) by Country
- 7.1.1 Europe Demerol (Meperidine) Sales by Country
- 7.1.2 Europe Demerol (Meperidine) Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Demerol (Meperidine) Market Facts & Figures by Type
- 7.3 Europe Demerol (Meperidine) Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Demerol (Meperidine) by Region
- 8.1.1 Asia Pacific Demerol (Meperidine) Sales by Region
- 8.1.2 Asia Pacific Demerol (Meperidine) Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Demerol (Meperidine) Market Facts & Figures by Type
- 8.3 Asia Pacific Demerol (Meperidine) Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Demerol (Meperidine) by Country
- 9.1.1 Latin America Demerol (Meperidine) Sales by Country
- 9.1.2 Latin America Demerol (Meperidine) Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Demerol (Meperidine) Market Facts & Figures by Type
- 9.3 Central & South America Demerol (Meperidine) Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Demerol (Meperidine) by Country
- 10.1.1 Middle East and Africa Demerol (Meperidine) Sales by Country
- 10.1.2 Middle East and Africa Demerol (Meperidine) Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Demerol (Meperidine) Market Facts & Figures by Type
- 10.3 Middle East and Africa Demerol (Meperidine) Market Facts & Figures by Application
11 Company Profiles
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Corporation Information
- 11.1.2 Purdue Pharma Description and Business Overview
- 11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Purdue Pharma Demerol (Meperidine) Products Offered
- 11.1.5 Purdue Pharma Related Developments
- 11.2 Egalet
- 11.2.1 Egalet Corporation Information
- 11.2.2 Egalet Description and Business Overview
- 11.2.3 Egalet Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Egalet Demerol (Meperidine) Products Offered
- 11.2.5 Egalet Related Developments
- 11.3 Boehringer Ingelheim
- 11.3.1 Boehringer Ingelheim Corporation Information
- 11.3.2 Boehringer Ingelheim Description and Business Overview
- 11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Boehringer Ingelheim Demerol (Meperidine) Products Offered
- 11.3.5 Boehringer Ingelheim Related Developments
- 11.4 Janssen
- 11.4.1 Janssen Corporation Information
- 11.4.2 Janssen Description and Business Overview
- 11.4.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Janssen Demerol (Meperidine) Products Offered
- 11.4.5 Janssen Related Developments
- 11.5 Sanofi
- 11.5.1 Sanofi Corporation Information
- 11.5.2 Sanofi Description and Business Overview
- 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sanofi Demerol (Meperidine) Products Offered
- 11.5.5 Sanofi Related Developments
- 11.6 Sun Pharmaceuticals
- 11.6.1 Sun Pharmaceuticals Corporation Information
- 11.6.2 Sun Pharmaceuticals Description and Business Overview
- 11.6.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sun Pharmaceuticals Demerol (Meperidine) Products Offered
- 11.6.5 Sun Pharmaceuticals Related Developments
- 11.7 Mallinckrodt Pharmaceuticals
- 11.7.1 Mallinckrodt Pharmaceuticals Corporation Information
- 11.7.2 Mallinckrodt Pharmaceuticals Description and Business Overview
- 11.7.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Products Offered
- 11.7.5 Mallinckrodt Pharmaceuticals Related Developments
- 11.8 Endo Pharmaceuticals
- 11.8.1 Endo Pharmaceuticals Corporation Information
- 11.8.2 Endo Pharmaceuticals Description and Business Overview
- 11.8.3 Endo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Endo Pharmaceuticals Demerol (Meperidine) Products Offered
- 11.8.5 Endo Pharmaceuticals Related Developments
- 11.9 Actavis
- 11.9.1 Actavis Corporation Information
- 11.9.2 Actavis Description and Business Overview
- 11.9.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Actavis Demerol (Meperidine) Products Offered
- 11.9.5 Actavis Related Developments
- 11.10 Pfizer
- 11.10.1 Pfizer Corporation Information
- 11.10.2 Pfizer Description and Business Overview
- 11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Pfizer Demerol (Meperidine) Products Offered
- 11.10.5 Pfizer Related Developments
- 11.1 Purdue Pharma
- 11.1.1 Purdue Pharma Corporation Information
- 11.1.2 Purdue Pharma Description and Business Overview
- 11.1.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Purdue Pharma Demerol (Meperidine) Products Offered
- 11.1.5 Purdue Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Demerol (Meperidine) Market Estimates and Projections by Region
- 12.1.1 Global Demerol (Meperidine) Sales Forecast by Regions 2021-2026
- 12.1.2 Global Demerol (Meperidine) Revenue Forecast by Regions 2021-2026
- 12.2 North America Demerol (Meperidine) Market Size Forecast (2021-2026)
- 12.2.1 North America: Demerol (Meperidine) Sales Forecast (2021-2026)
- 12.2.2 North America: Demerol (Meperidine) Revenue Forecast (2021-2026)
- 12.2.3 North America: Demerol (Meperidine) Market Size Forecast by Country (2021-2026)
- 12.3 Europe Demerol (Meperidine) Market Size Forecast (2021-2026)
- 12.3.1 Europe: Demerol (Meperidine) Sales Forecast (2021-2026)
- 12.3.2 Europe: Demerol (Meperidine) Revenue Forecast (2021-2026)
- 12.3.3 Europe: Demerol (Meperidine) Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Demerol (Meperidine) Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Demerol (Meperidine) Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Demerol (Meperidine) Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Demerol (Meperidine) Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Demerol (Meperidine) Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Demerol (Meperidine) Sales Forecast (2021-2026)
- 12.5.2 Latin America: Demerol (Meperidine) Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Demerol (Meperidine) Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Demerol (Meperidine) Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Demerol (Meperidine) Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Demerol (Meperidine) Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Demerol (Meperidine) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Demerol (Meperidine) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Demerol (Meperidine) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Demerol (Meperidine) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Demerol (Meperidine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Demerol (Meperidine) market is segmented into
Powder
Liquid
Segment by Application, the Demerol (Meperidine) market is segmented into
Anesthesia
Cough Treatment
Diarrhea Treatment
Regional and Country-level Analysis
The Demerol (Meperidine) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Demerol (Meperidine) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Demerol (Meperidine) Market Share Analysis
Demerol (Meperidine) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Demerol (Meperidine) business, the date to enter into the Demerol (Meperidine) market, Demerol (Meperidine) product introduction, recent developments, etc.
The major vendors covered:
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer